Terms: = Lung cancer AND CEACAM5, CEA AND Prognosis
448 results:
1. [Expression and prognostic significance of KAP1 gene in malignant pleural mesothelioma].
Mei W; Wang XM; Liu RA; Xiong W; Zhang YP
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2024 Apr; 42(4):258-267. PubMed ID: 38677988
[No Abstract] [Full Text] [Related]
2. [Clinical characteristics and prognosis analysis of 17 cases of SMARCA4-deficient chest tumors].
Cao XN; Li Z; Wang QY
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Apr; 47(4):325-331. PubMed ID: 38599807
[No Abstract] [Full Text] [Related]
3. Factors influencing blood tumor marker concentrations in the absence of neoplasia.
Trapé J; Fernández-Galán E; Auge JM; Carbonell-Prat M; Filella X; Miró-Cañís S; González-Fernández C;
Tumour Biol; 2024; 46(s1):S35-S63. PubMed ID: 38517826
[TBL] [Abstract] [Full Text] [Related]
4. CT-guided radioactive
Song M; Zhou X; Hou R; Sigdel M; Liu Y; Zhang C; Xu K; Han X; Jiao D
BMC Cancer; 2024 Feb; 24(1):265. PubMed ID: 38403626
[TBL] [Abstract] [Full Text] [Related]
5. Relevance of tumor markers for prognosis and predicting therapy response in non-small cell lung cancer patients: A CEPAC-TDM biomarker substudy.
Geiger K; Joerger M; Roessler M; Hettwer K; Ritter C; Simon K; Uhlig S; Holdenrieder S
Tumour Biol; 2024; 46(s1):S191-S206. PubMed ID: 38363625
[TBL] [Abstract] [Full Text] [Related]
6. Correlation Analysis of KCNQ1 Gene Polymorphism with Blood Indexes and prognosis of Non-Small Cell lung cancer.
Xie G; Yang Y; Zeng W; Liu Y; Gui B
Clin Lab; 2024 Feb; 70(2):. PubMed ID: 38345992
[TBL] [Abstract] [Full Text] [Related]
7. sPD-L1 and sPD-L2 in plasma of patients with lung cancer and their clinical significance.
Han S; Zhang Y; Yuan J; Wu Y; Zhou Y; Zhou Y; Li X; Zhou S
Cytokine; 2024 Apr; 176():156532. PubMed ID: 38330638
[TBL] [Abstract] [Full Text] [Related]
8. The emerging roles of ceaCAM6 in human cancer (Review).
Wu G; Wang D; Xiong F; Wang Q; Liu W; Chen J; Chen Y
Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38240103
[TBL] [Abstract] [Full Text] [Related]
9. IL-17A as a new circulating bioindicator for non-small cell lung cancer diagnosis and prognosis.
Wang JX; Xu XJ; Zhu ZM; Cao WL; Yang ZP; Zhen JL; Wu YY; Lu FM; Liu SW
Eur Rev Med Pharmacol Sci; 2023 Dec; 27(24):12004-12011. PubMed ID: 38164862
[TBL] [Abstract] [Full Text] [Related]
10. A novel model for predicting the prognosis of postoperative intrahepatic cholangiocarcinoma patients.
Lv Y; Liu H; He P; Xie S; Yin X; Cai Y; Wu H
Sci Rep; 2023 Nov; 13(1):19267. PubMed ID: 37935735
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic value of blood-based protein biomarkers in non-small cell lung cancer: A critical review and 2008-2022 update.
Trulson I; Holdenrieder S
Tumour Biol; 2024; 46(s1):S111-S161. PubMed ID: 37927288
[TBL] [Abstract] [Full Text] [Related]
12. Preoperative predictors for recurrence sites associated with poor post-recurrence survival after surgery of non-small cell lung cancer: a multicenter study.
Isaka T; Adachi H; Murakami K; Miura J; Kikunishi N; Shigeta N; Kudo Y; Miyata Y; Okada M; Ikeda N; Ito H
BMC Cancer; 2023 Nov; 23(1):1064. PubMed ID: 37926846
[TBL] [Abstract] [Full Text] [Related]
13. POU2F3-Expressing Small Cell lung Carcinoma and Large Cell Neuroendocrine Carcinoma Show Morphologic and Phenotypic Overlap.
Jimbo N; Ohbayashi C; Takeda M; Fujii T; Mitsui S; Tsukamoto R; Tanaka Y; Itoh T; Maniwa Y
Am J Surg Pathol; 2024 Jan; 48(1):4-15. PubMed ID: 37904277
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic value of tumor markers ProGRP, NSE and CYFRA 21-1 in patients with small cell lung cancer and chemotherapy-induced remission.
Muley T; Herth FJ; Heussel CP; Kriegsmann M; Thomas M; Meister M; Schneider MA; Wehnl B; Mang A; Holdenrieder S
Tumour Biol; 2024; 46(s1):S219-S232. PubMed ID: 37840518
[TBL] [Abstract] [Full Text] [Related]
15. Chemical Proteomic Approach for In-Depth Glycosylation Profiling of Plasma Carcinoembryonic Antigen in cancer Patients.
Chen J; Yang L; Li C; Zhang L; Gao W; Xu R; Tian R
Mol Cell Proteomics; 2023 Nov; 22(11):100662. PubMed ID: 37820924
[TBL] [Abstract] [Full Text] [Related]
16. Analysis of prognostic factors in different grades of histologic differentiation in colorectal cancer patients receiving preoperative neoadjuvant chemotherapy and establishment of prognostic nomograms for moderately differentiated grade.
Luo X; E Y; Wu J; Lu C; Zhang J
Int J Colorectal Dis; 2023 Sep; 38(1):237. PubMed ID: 37747505
[TBL] [Abstract] [Full Text] [Related]
17. Rapid Reduction of cea and Stable Metastasis in an
Kubota Y; Han Q; Morinaga S; Tsunoda T; Hoffman RM
In Vivo; 2023; 37(5):2134-2138. PubMed ID: 37652473
[TBL] [Abstract] [Full Text] [Related]
18. Elastic modulus-reflected liver lesion stiffness relates to worse prognosis in pancreatic cancer patients with liver metastasis.
Dong S; Miao X; Zhang K; Zhu X; Gao Y; Chen H
World J Surg Oncol; 2023 Aug; 21(1):262. PubMed ID: 37620975
[TBL] [Abstract] [Full Text] [Related]
19. Development and validation of prediction models for the prognosis of colon cancer with lung metastases: a population-based cohort study.
Ma Z; Yang S; Yang Y; Luo J; Zhou Y; Yang H
Front Endocrinol (Lausanne); 2023; 14():1073360. PubMed ID: 37583430
[TBL] [Abstract] [Full Text] [Related]
20. The predictive role of hematologic markers in resectable NSCLC patients treated with neoadjuvant chemoimmunotherapy: a retrospective cohort study.
Liu W; Ren S; Yang L; Xiao Y; Zeng C; Chen C; Wu F; Hu Y
Int J Surg; 2023 Nov; 109(11):3519-3526. PubMed ID: 37578441
[TBL] [Abstract] [Full Text] [Related]
[Next]
